Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059

By Green A.R.   Ashwood T.   Odergren T.   Jackson D.M.  

Pharmacology and Therapeutics, Vol. 100, Iss. 3, 2003-12 ,pp. : 195-214

Elsevier

Access to resources Recommend Favorite

Nitrone-Related Therapeutics: Potential of NXY-059 for the Treatment of Acute Ischaemic Stroke

By Kirk R. Maples  

CNS Drugs, Vol. 18, Iss. 15, 2004-01 ,pp. : 1071-1084

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetic Modelling and Estimation of Dosing Strategy for NXY-059, a Nitrone Being Developed for Stroke

By Jönsson Siv  

Clinical Pharmacokinetics, Vol. 44, Iss. 8, 2005-01 ,pp. : 863-878

Adis International

Access to resources Recommend Favorite

Commentary : Hypothesis Focused Ultrasound and NXY-059 in Experimental Cerebral Ischemia: A New Therapeutic Opportunity?

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 9, 2016-11 ,pp. : 1010-1013

Bentham Science Publishers

Access to resources Recommend Favorite

The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes

By Noyer M.   Gillard M.   Matagne A.   Henichart J.-P.   Wulfert E.  

European Journal of Pharmacology, Vol. 286, Iss. 2, 1995-11 ,pp. : 137-146

Elsevier

Access to resources Recommend Favorite